Financials

  • Market Capitalization 4.6 M
  • Employee 7
  • Founded 2016
  • CEO N/A
  • Website www.alzamend.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZMXG7M8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.52
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4980
MBIO
Mustang Bio, Inc. - Common Stock
0.66 USD0.00%-2.94%-9.59%-23.96%4.78 M USD
4981
CLGN
CollPlant Biotechnologies Ltd. - Ordinary Shares
0.37 USD+5.71%+2.78%+8.82%-77.02%4.74 M USD
4989
LIMN
Liminatus Pharma, Inc. - Class A Common Stock
0.10 USD-9.09%-16.67%-16.67%-98.36%4.49 M USD
4993
FBLG
FibroBiologics, Inc. - Common Stock
0.85 USD-1.16%+3.66%-7.61%+30.77%4.43 M USD

Notizie